Publication | Open Access
Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by <sup>18</sup>F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials
24
Citations
15
References
2012
Year
These data exemplify the role of (18)F-FDG PET for guiding the selection of novel investigational drugs, choosing dose in early-phase clinical development, and predicting nonresponding patients early in treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1